AltruBio
Biotech · Private
T-cell signaling modulators for autoimmune and inflammatory disease treatment
altrubio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 13
- 2 granted · 11 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1351 | ADVAC, LLC | — | — |
| 1352 | CALEO BIOTECHNOLOGIES, INC. | — | — |
| 1353 | SOLVEXA, LLC | — | — |
| 1354 | AltruBio | — | — |
| 1355 | Allegro 3D, Inc. | — | — |
| 1356 | FoodSource Lure Corporation | — | — |
| 1357 | TANDA BIOTECH CORPORATION | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods Of Using ANTI-PSGL-1 Antibodies In Combination With Jak Inhibitors To Treat T-cell Mediated Inflammatory Diseases Or Cancersapplication
- Methods Of Using ANTI-PSGL-1 Antibodies In Combination With Jak Inhibitors To Treat T-cell Mediated Inflammatory Diseases Or Cancersgranted
- Tetravalent ANTI-PSGL-1 Antibodies And Uses Thereofapplication
- ANTI-PSGL-1 Antibodies And Uses Thereofapplication
- Tetravalent ANTI-PSGL-1 Antibodies And Uses Thereofapplication
- ANTI-PSGL-1 Antibodies And Uses Thereofgranted
- Tetravalent ANTI-PSGL-1 Antibodies And Uses Thereofapplication
- Methods Of Using Tetravalent ANTI-PSGL-1 Antibodies To Treat Ulcerative Colitisapplication
- ANTI-PSGL-1 Antibodies And Uses Thereofapplication
- Methods Of Using ANTI-PSGL-1 Antibodies In Combination With Jak Inhibitors To Treat T-cell Mediated Inflammatory Diseases Or Cancersapplication
- Methods Of Using ANTI-PSGL-1 Antibodies In Combination With Jak Inhibitors To Treat T-cell Mediated Inflammatory Diseases Or Cancersapplication
- Methods Of Using Tetravalent ANTI-PSGL-1 Antibodies To Treat Ulcerative Colitisapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.